Inactive Instrument

Highlights Oxford BioMedica plc London S.E.

Equities

GB0006648157_GB

GB0006648157

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

FTSE 100 as investors look to Fed rate decision	Apr. 29	AN
Oxford BioMedica bullish; Petrofac slumps	Apr. 29	AN
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M	Apr. 29	MT
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024	Apr. 29	CI
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	Mar. 20	AN
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	Mar. 20	MT
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	Mar. 05	AN
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024	Mar. 05	CI
Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition	Jan. 29	MT
Institut Merieux ups stake in Oxford BioMedica toward 10%	Jan. 29	AN
Oxford Biomedica plc completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH ?6.1 million	Jan. 28	CI
Oxford BioMedica posts optimistic outlook on uptick in contract value	Dec. 07	AN
Oxford Biomedica plc Provides Business Update	Dec. 07	CI
Oxford Biomedica to Buy ABL Europe from Institut Mérieux	Dec. 04	MT
Oxford BioMedica buys ABL Europe for consideration of EUR15 million	Dec. 04	AN
Oxford Biomedica plc entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH.	Dec. 03	CI
Oxford Biomedica plc entered into a sale and purchase agreement to acquire ABL EUROPE S.A.S. from TSGH for ?15 million.	Dec. 03	CI
Oxford BioMedica shares up, in talks to buy ABL Europe but loss widens	23-09-20	AN
Oxford BioMedica Gains 10% Amid Talks to Acquire ABL Europe	23-09-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Oxford BioMedica plc London S.E.

Equities

GB0006648157_GB

GB0006648157

Highlights

Filters